Detalhe da pesquisa
1.
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer.
N Engl J Med
; 386(6): 556-567, 2022 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35139274
2.
21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer.
N Engl J Med
; 385(25): 2336-2347, 2021 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34914339
3.
Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet Oncol
; 24(2): 162-174, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36623515
4.
Intratumour heterogeneity, from hypothesis to the clinic.
Br J Cancer
; 128(3): 459-460, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36216884
5.
Breast cancers with high proliferation and low ER-related signalling have poor prognosis and unique molecular features with implications for therapy.
Br J Cancer
; 129(12): 2025-2033, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37935787
6.
Molecular Characterization of HER2-Low Invasive Breast Carcinoma by Quantitative RT-PCR Using Oncotype DX Assay.
Oncologist
; 28(10): e973-e976, 2023 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37656608
7.
Variable Landscape of PD-L1 Expression in Breast Carcinoma as Detected by the DAKO 22C3 Immunohistochemistry Assay.
Oncologist
; 28(4): 319-326, 2023 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36866462
8.
Pembrolizumab for Early Triple-Negative Breast Cancer.
N Engl J Med
; 382(9): 810-821, 2020 02 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32101663
9.
Intratumor spatial heterogeneity in programmed death-ligand 1 (PD-L1) protein expression in early-stage breast cancer.
Breast Cancer Res Treat
; 201(2): 289-298, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37378695
10.
Neoadjuvant Immunotherapy in Early, Triple-Negative Breast Cancers: Catching Up with the Rest.
Ann Surg Oncol
; 30(11): 6441-6449, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37349612
11.
Persistence to extended adjuvant endocrine therapy following Breast Cancer Index (BCI) testing in women with early-stage hormone receptor-positive (HR +) breast cancer.
BMC Cancer
; 23(1): 606, 2023 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37391697
12.
Vitamin D Insufficiency as a Risk Factor for Paclitaxel-Induced Peripheral Neuropathy in SWOG S0221.
J Natl Compr Canc Netw
; 21(11): 1172-1180.e3, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37935109
13.
Impact of Anti-HER2 Therapy Alone and With Weekly Paclitaxel on the Ovarian Reserve of Young Women With HER2-Positive Breast Cancer.
J Natl Compr Canc Netw
; 21(1): 33-41.e16, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36634607
14.
Thymidine kinase activity levels in serum can identify HR+ metastatic breast cancer patients with a low risk of early progression (SWOG S0226).
Biomarkers
; 28(3): 313-322, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36647745
15.
Treatment efficacy score: a better surrogate for arm-level survival differences in neoadjuvant breast cancer trials?
Future Oncol
; 19(28): 1945-1951, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37767612
16.
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients.
Lancet Oncol
; 23(1): 149-160, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34902335
17.
PD-L1 protein expression in relation to recurrence score values in early-stage ER + breast cancer.
Breast Cancer Res Treat
; 196(1): 221-227, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36028784
18.
Patterns of treatment with everolimus exemestane in hormone receptor-positive HER2-negative metastatic breast cancer in the era of targeted therapy.
Breast Cancer Res
; 23(1): 14, 2021 01 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33514405
19.
Quantitative assessment of the immune microenvironment in African American Triple Negative Breast Cancer: a case-control study.
Breast Cancer Res
; 23(1): 113, 2021 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34906209
20.
Clinicopathologic and Genomic Landscape of Breast Carcinoma Brain Metastases.
Oncologist
; 26(10): 835-844, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34105210